NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/06/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization7.69 mln
Float7.41 mln
Earnings Date08/06/2026
Piotroski F-Score
2
/ 9
Weak
Relative Strength
40
/ 100
Slightly lagging
Debt / Equity
0.00
Debt-free
ROE
-63.65
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Aprea Therapeutics is a Pennsylvania-based company working to bring new cancer treatments to patients. The company is currently testing two experimental drugs in early-stage clinical trials ? one targeting a protein called WEE1 and another targeting ATR ? both designed to fight solid tumors by disrupting the way cancer cells repair their DNA. Its approach focuses on exploiting specific weaknesses in cancer cells to slow or stop tumor growth.
